High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda
Long-acting injectable antiretroviral treatment (LAI ART), such as a bimonthly injection of cabotegravir/rilpivirine, is a promising HIV treatment option. LAI ART may particularly benefit people who are reluctant to initiate or are poorly adherent to daily oral pills and not virally suppressed. Howe...
Saved in:
Published in | AIDS patient care and STDs Vol. 37; no. 6; p. 316 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2023
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Long-acting injectable antiretroviral treatment (LAI ART), such as a bimonthly injection of cabotegravir/rilpivirine, is a promising HIV treatment option. LAI ART may particularly benefit people who are reluctant to initiate or are poorly adherent to daily oral pills and not virally suppressed. However, the acceptability and feasibility of LAI ART among individuals with viremia in Africa has not been well studied. We conducted qualitative in-depth interviews with 38 people living with HIV with viral load ≥1000 copies/mL and 15 medical and nursing staff, and 6 focus group discussions with peer health workers, to examine acceptability and feasibility of LAI ART in south-central Uganda. Transcripts were thematically analyzed through a team-based framework approach. Most people living with HIV reacted positively toward LAI ART and endorsed interest in taking it themselves. Most felt LAI ART would make adherence easier by reducing the challenge with remembering daily pills, particularly in the context of busy schedules, travel, alcohol use, and dietary requirements. Participants also appreciated the privacy of injections, reducing the likelihood of stigma or inadvertent HIV serostatus disclosure with pill possession. Concerns about LAI ART included side effects, perceived medication effectiveness, fear of injection, and medical mistrust and conspiracy beliefs. Health workers and participants with viremia also noted health system challenges, such as stockouts and monitoring treatment failure. However, they felt the health system could overcome these challenges. Implementation complexities must be addressed as LAI ART is introduced and expanded in Africa to best support viral suppression and address HIV care continuum gaps. |
---|---|
AbstractList | Long-acting injectable antiretroviral treatment (LAI ART), such as a bimonthly injection of cabotegravir/rilpivirine, is a promising HIV treatment option. LAI ART may particularly benefit people who are reluctant to initiate or are poorly adherent to daily oral pills and not virally suppressed. However, the acceptability and feasibility of LAI ART among individuals with viremia in Africa has not been well studied. We conducted qualitative in-depth interviews with 38 people living with HIV with viral load ≥1000 copies/mL and 15 medical and nursing staff, and 6 focus group discussions with peer health workers, to examine acceptability and feasibility of LAI ART in south-central Uganda. Transcripts were thematically analyzed through a team-based framework approach. Most people living with HIV reacted positively toward LAI ART and endorsed interest in taking it themselves. Most felt LAI ART would make adherence easier by reducing the challenge with remembering daily pills, particularly in the context of busy schedules, travel, alcohol use, and dietary requirements. Participants also appreciated the privacy of injections, reducing the likelihood of stigma or inadvertent HIV serostatus disclosure with pill possession. Concerns about LAI ART included side effects, perceived medication effectiveness, fear of injection, and medical mistrust and conspiracy beliefs. Health workers and participants with viremia also noted health system challenges, such as stockouts and monitoring treatment failure. However, they felt the health system could overcome these challenges. Implementation complexities must be addressed as LAI ART is introduced and expanded in Africa to best support viral suppression and address HIV care continuum gaps. |
Author | Kennedy, Caitlin E Jackson, Jade Zhao, Tongying Kigozi, Godfrey Rosen, Joseph G Grabowski, M Kate Nakyanjo, Neema Quinn, Thomas C Nalugoda, Fred Nabakka, Proscovia Kagaayi, Joseph Vo, Anh Van Chang, Larry W Reynolds, Steven J Ddaaki, William G Nakubulwa, Rosette Nakigozi, Gertrude |
Author_xml | – sequence: 1 givenname: Caitlin E orcidid: 0000-0001-6820-063X surname: Kennedy fullname: Kennedy, Caitlin E organization: Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 2 givenname: Tongying surname: Zhao fullname: Zhao, Tongying organization: Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 3 givenname: Anh Van surname: Vo fullname: Vo, Anh Van organization: Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 4 givenname: Rosette surname: Nakubulwa fullname: Nakubulwa, Rosette organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 5 givenname: Proscovia surname: Nabakka fullname: Nabakka, Proscovia organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 6 givenname: Jade surname: Jackson fullname: Jackson, Jade organization: Department of Pathology and School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 7 givenname: Joseph G orcidid: 0000-0003-4991-4033 surname: Rosen fullname: Rosen, Joseph G organization: Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 8 givenname: Larry W surname: Chang fullname: Chang, Larry W organization: Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 9 givenname: Steven J surname: Reynolds fullname: Reynolds, Steven J organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US National Institutes of Health, Bethesda, Maryland, USA – sequence: 10 givenname: Thomas C surname: Quinn fullname: Quinn, Thomas C organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US National Institutes of Health, Bethesda, Maryland, USA – sequence: 11 givenname: Gertrude surname: Nakigozi fullname: Nakigozi, Gertrude organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 12 givenname: Godfrey surname: Kigozi fullname: Kigozi, Godfrey organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 13 givenname: Joseph surname: Kagaayi fullname: Kagaayi, Joseph organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 14 givenname: Fred surname: Nalugoda fullname: Nalugoda, Fred organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 15 givenname: William G surname: Ddaaki fullname: Ddaaki, William G organization: Rakai Health Sciences Program, Kalisizo, Uganda – sequence: 16 givenname: M Kate surname: Grabowski fullname: Grabowski, M Kate organization: Department of Pathology and School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 17 givenname: Neema surname: Nakyanjo fullname: Nakyanjo, Neema organization: Rakai Health Sciences Program, Kalisizo, Uganda |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37294280$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kMtOwzAURC0Eog9YskX-gRTbedhZRhUllSrBoo9l5dg3qUviRI4p6ifxlwQoq5HuzJkrzQRd29YCQg-UzCgR6ZPs1IwRFs4IofwKjWkc84BHUTpCk74_EkIEi8ktGoWcpRETZIy-clMdcKYUdF4Wpjb-jKXV-A2cAnMCjRcge3Nx2hKvWlsFmfLGVnhpj6AGrAacWW8ceNeejJM1XjuQvgHrcdYMwFDXdkNqZU4_3KfxB5wvt3h3aHHmAG8HtjHq93MOsh7sXevewfXYWLyphru8QzelrHu4v-gUbRbP63kerF5flvNsFaiQUR9oHVNJWcIKpTnwEJI4lTxOI54kURIrKEUodMlVkcpY8hLKUguRiJRoVZQ0YlP0-NfbfRQN6H3nTCPdef-_GfsGSrFw-Q |
CitedBy_id | crossref_primary_10_1089_apc_2023_0248 crossref_primary_10_1089_apc_2024_0093 crossref_primary_10_2196_56892 crossref_primary_10_1097_QAD_0000000000003760 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1089/apc.2023.0017 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1557-7449 |
ExternalDocumentID | 37294280 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | Uganda |
GeographicLocations_xml | – name: Uganda |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: F31 MH126796 – fundername: NIAID NIH HHS grantid: R01 AI155080 |
GroupedDBID | --- .XZ 04C 0R~ 0VX 1-M 23M 354 36B 39C 4.4 53G 5GY 5RE 6J9 6PF AAWTL ABBKN ABIVO ABJNI ACGFO ACGFS ACHQT ACNCT ACPRK ADBBV AENEX AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS BKOMP BMSDO BNQNF CAG CGR COF CS3 CUY CVF EAS EBS ECM EDH EGL EHN EIF EJD EMB EMOBN EPT ESX F5P IM4 J5H MV1 NPM NQHIM O9- OBH OHH OVD PQQKQ RIG RML RMSOB TAE TEORI UE5 UKR WQ9 YYQ |
ID | FETCH-LOGICAL-c321t-dd51a1262bcd7e73e659a7594766465cef838df7cb9a5a7feffd886890dcbf142 |
IngestDate | Wed Oct 23 09:32:37 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Uganda long-acting antiretroviral therapy injectable cabotegravir/rilpivirine viremia |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c321t-dd51a1262bcd7e73e659a7594766465cef838df7cb9a5a7feffd886890dcbf142 |
ORCID | 0000-0003-4991-4033 0000-0001-6820-063X |
PMID | 37294280 |
ParticipantIDs | pubmed_primary_37294280 |
PublicationCentury | 2000 |
PublicationDate | 2023-06-00 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | AIDS patient care and STDs |
PublicationTitleAlternate | AIDS Patient Care STDS |
PublicationYear | 2023 |
SSID | ssj0008250 |
Score | 2.4342675 |
Snippet | Long-acting injectable antiretroviral treatment (LAI ART), such as a bimonthly injection of cabotegravir/rilpivirine, is a promising HIV treatment option. LAI... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 316 |
SubjectTerms | Anti-HIV Agents - therapeutic use Anti-Retroviral Agents - therapeutic use Feasibility Studies HIV Infections - drug therapy Humans Trust Uganda Viremia - drug therapy |
Title | High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37294280 |
Volume | 37 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9NAEMdXKUiolwrE-6U5cLNcHL_WPlotKCCIKpGUiku1Xu82FdSOWgcE34ivwydiZnftOKWIx8WybNlZeX4Z74xn_svYs5LjJCELhM9jrfw4Fzn-50Ja7kUG-DauMi0oNfB2mk7m8euj5Gg0-jGoWlq15a78dmVfyf9YFY-hXalL9h8s298UD-A-2he3aGHc_pWNqUiD1ntQy9bKbVsxpQMqVkEvVnk4wXPlr-ZD-pumPvEL2doqAcrAmMapom7R8bWUXDDt-n3teWFWIjowReYYvX_uE7cTDBrfLxqvOFfeIV575lRfXVMTZeCpMfi09uYnogv6O63bV_vvOjlXI4xtq0dn-xdXOP89WtcHb9P3S3xYCJPcneHIvnavXVowzLbr1AvvcM37VHxclatPX-wEubnoy5pcmiOM1uVYu8q55oQjUVbgtPPdVjDGMTp0xJHt4PzlBRFkpK8qlqReGZK4re0cHcCyPDO00OdMDM2CP5-9pNfdndpiWzwjnzul_JGbG2A8HjilVxzJ841xbLMb3bWXYhwz15ndZDsuSIHCEneLjVR9m30n2mCDNkDLQU8bDGiDRsOANljTBpu0QU8bGNrA0gaWNiDaAGkDpA3Ho8DRZn7Z0gaONjitwdJ2h81fvpjtTXy30Icvo3Dc-lWVjMU4TMNSVlzxSKVJLniSxzxN4zSRSmdRVmkuy1wkgmuldZVlaZYHlSz1OA7vsmt1U6v7DFQaqRinqKUQVaykFnj9OC6jSshIiVQ-YPfskz1eWjWX4-6ZP_ztmUdse03kY3Zdo_tQT3Au2pZPjXl_AnC6j8w |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Acceptability+and+Perceived+Feasibility+of+Long-Acting+Injectable+Antiretroviral+Treatment+Among+People+Living+with+HIV+Who+Are+Viremic+and+Health+Workers+in+Uganda&rft.jtitle=AIDS+patient+care+and+STDs&rft.au=Kennedy%2C+Caitlin+E&rft.au=Zhao%2C+Tongying&rft.au=Vo%2C+Anh+Van&rft.au=Nakubulwa%2C+Rosette&rft.date=2023-06-01&rft.eissn=1557-7449&rft.volume=37&rft.issue=6&rft.spage=316&rft_id=info:doi/10.1089%2Fapc.2023.0017&rft_id=info%3Apmid%2F37294280&rft_id=info%3Apmid%2F37294280&rft.externalDocID=37294280 |